Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database

INTRODUCTION: In patients with chronic obstructive pulmonary disease (COPD), treatment with long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) combination therapy significantly improves lung function versus LABA/inhaled corticosteroid (ICS). To investigate whether LAMA/LABA cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Quint, Jennifer K., Montonen, Jukka, Esposito, Daina B., He, Xintong, Koerner, Leslie, Wallace, Laura, de la Hoz, Alberto, Miravitlles, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107175/
https://www.ncbi.nlm.nih.gov/pubmed/33721209
http://dx.doi.org/10.1007/s12325-021-01646-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107175/
https://www.ncbi.nlm.nih.gov/pubmed/33721209
http://dx.doi.org/10.1007/s12325-021-01646-5

Ejemplares similares